Ultimo, Amelia et al. [81] developed a toll-like receptor 3 (TLR3) delivery method relying on mesoporous silica NPs capped with synthetic twofold-stranded polyinosinic-polycytidylic acid (poly(I:C)) RNA for a controlled burden transfer in SK-BR-3 BC cells. Here, TLR3 is linked to breast cancer.